Controlled release of substances bound to fibrin-anchors or of DNA

Drug Delivery

Volumn 16, Issue 2, 2009, Pages 102-107

  Morton, T J ^a,b   Furst W ^a   Griensven, M Van ^a,b   Redl, H ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b Austrian Cluster for Tissue Regeneration   (Austria)

Author keywords

EDC coupling; Fibrin; Plasmid DNA delivery; Smart hydrogel; Tissue engineering

Indexed keywords

ALBUMIN; BIOTIN; DNA; FIBRIN; FIBRIN GLUE; FIBRONECTIN; N HYDROXYSUCCINIMIDE; THROMBIN; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR;

ARTICLE; BINDING ASSAY; BLOOD CLOTTING; CHEMICAL REACTION; CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG BINDING; PRIORITY JOURNAL; PROTEIN MODIFICATION;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTIBODIES; BETA-GALACTOSIDASE; BIOLOGICAL AVAILABILITY; CATTLE; CYTOCHROMES C; DELAYED-ACTION PREPARATIONS; DNA; FIBRIN; FIBRINOGEN; FIBRONECTINS; PHARMACEUTICAL PREPARATIONS; PLASMIDS; SERUM ALBUMIN; STREPTAVIDIN; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 62249180927     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802605608     Document Type: Article

References (20)

1. Richardson TP, Murphy WL, Mooney DJ (2001). Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit Rev Eukaryot Gene Expr, 11, 47-58.
2. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z (1991). Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci, 16, 268-71.
3. Wong C, Inman E, Spaethe R, Helgerson S (2003). Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost, 89, 573-582.
4. MacPhee M, Singh M, Brady R, Akhyani N, Liau G, Lasa C, et al. (1996). Fibrin sealant: a versatile delivery vehicle for drugs and biologics. In Surgical Adhesives and Sealants: Current Technology and Applications, (Sierra, DH and Saltz R., Eds), pp. 109-20. Technomic Publishing, Lancaster, PA.
5. Spotnitz WD (2001). Commercial fibrin sealants in surgical care. Am J Surg, 182, 8S-14S.
6. Van Hinsbergh VW, Collen A, Koolwijk P (2001). Role of fibrin matrix in angiogenesis. Ann NY Acad Sci, 936, 426-37.
7. Martinowitz U, Saltz R (1996). Fibrin sealant. Curr Opin Hematol, 3, 395-402.
8. Mosesson MW, Siebenlist KR, Meh DA (2001). The structure and biological features of fibrinogen and fibrin. Ann NY Acad Sci, 936, 11-30.
9. Sahni A, Guo M, Sahni SK, Francis CW (1998). Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood, 104, 409-14.
10. Sahni A, Odrljin T, Francis CW (2004). Binding of basic fibroblast growth factor to fibrinogen and fibrin. J Biol Chem, 273, 7554-9.
11. Furst W, Banerjee A, Redl H (2007). Comparison of structure, strength and cytocompatibility of a fibrin matrix supplemented either with tranexamic acid or aprotinin. J Biomed Mater Res B Appl Biomater, 82, 109-14.
12. Liu CY, Nossel HL, Kaplan KL (1979). The binding of thrombin by fibrin. J Biol Chem, 254, 10421-5.
13. Mosher DF, Johnson RB (1983). Specificity of fibronectin-fibrin cross-linking. Ann NY Acad Sci, 408, 583-94.
14. Locksley RM, Killeen N, Lenardo MJ (2001). The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell, 104, 487-501.
15. Lyon ME, Fine JS, Henderson PJ, Lyon AW (1995). D-phenylalanyl-L-prolyl- L-arginine chloromethyl ketone (PPACK): alternative anticoagulant to heparin salts for blood gas and electrolyte specimens. Clin Chem, 41, 1038-41.
16. Harlow E and Lane D (1988). Antibodies, Chapter 5, pp 84-85.
17. Sambrook J and Russell (1989). Molecular Cloning, Vol 1, Chapter 1.
18. Currie LJ, Sharpe JR, Martin R (2001). The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. Plast Reconstr Surg, 108, 1713-26.
19. Lee H, Chung HJ, Park TG (2007). Perspectives on local and sustained delivery of angiogenic growth factors. J Bioactive Compat Polym, 22, 89-114.
20. Richardson TP, Peters MC, Ennett AB, Mooney DJ (2001). Polymeric system for dual growth factor delivery. Nat Biotechnol, 19, 1029-34.